Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family

Colorectal cancer (CRC) is among the most frequent causes of cancer-related deaths worldwide. Thus, there is a need for the development of new therapeutic approaches for the treatment of CRC. Accumulating evidence has revealed that niclosamide, an anthelminthic drug, exerts antitumor activity in sev...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int J Mol Med
Prif Awduron: Suliman, Mohammed A., Zhang, Zhenxing, Na, Heya, Ribeiro, Ailton L.L., Zhang, Yu, Niang, Bachir, Hamid, Abdu Salim, Zhang, Hua, Xu, Lijie, Zuo, Yunfei
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: D.A. Spandidos 2016
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4990307/
https://ncbi.nlm.nih.gov/pubmed/27460529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2016.2689
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg